NO20034740L - Anvendelse av galantamin for behandling av patologiske manifestasjoner i sentralnervesystemet grunnet forgiftning med psykotropiskesubstanser - Google Patents
Anvendelse av galantamin for behandling av patologiske manifestasjoner i sentralnervesystemet grunnet forgiftning med psykotropiskesubstanserInfo
- Publication number
- NO20034740L NO20034740L NO20034740A NO20034740A NO20034740L NO 20034740 L NO20034740 L NO 20034740L NO 20034740 A NO20034740 A NO 20034740A NO 20034740 A NO20034740 A NO 20034740A NO 20034740 L NO20034740 L NO 20034740L
- Authority
- NO
- Norway
- Prior art keywords
- galantamine
- poisoning
- treatment
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10119862A DE10119862A1 (de) | 2001-04-24 | 2001-04-24 | Verwendung von Galanthamin zur Behandlung von Krankheitserscheinungen des zentralen Nervensystems aufgrund von Intoxikationen mit psychotropen Substanzen |
PCT/EP2002/004277 WO2002085370A1 (fr) | 2001-04-24 | 2002-04-18 | Utilisation de galanthamine pour traiter des symptomes du systeme verveux central provoques par des intoxications dues a des substances psychotropes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20034740D0 NO20034740D0 (no) | 2003-10-23 |
NO20034740L true NO20034740L (no) | 2003-10-23 |
Family
ID=7682409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20034740A NO20034740L (no) | 2001-04-24 | 2003-10-23 | Anvendelse av galantamin for behandling av patologiske manifestasjoner i sentralnervesystemet grunnet forgiftning med psykotropiskesubstanser |
Country Status (27)
Country | Link |
---|---|
US (1) | US8207159B2 (fr) |
EP (1) | EP1383507B1 (fr) |
JP (1) | JP2004531533A (fr) |
KR (1) | KR20040005934A (fr) |
CN (1) | CN100400043C (fr) |
AR (1) | AR033468A1 (fr) |
AT (1) | ATE378052T1 (fr) |
AU (1) | AU2002308148B2 (fr) |
BR (1) | BR0209126A (fr) |
CA (1) | CA2444818C (fr) |
CZ (1) | CZ20032789A3 (fr) |
DE (2) | DE10119862A1 (fr) |
DK (1) | DK1383507T3 (fr) |
EA (1) | EA200301135A1 (fr) |
ES (1) | ES2296990T3 (fr) |
HK (1) | HK1062401A1 (fr) |
HU (1) | HUP0401123A3 (fr) |
IL (2) | IL158382A0 (fr) |
MX (1) | MXPA03009765A (fr) |
NO (1) | NO20034740L (fr) |
NZ (1) | NZ529004A (fr) |
PL (1) | PL207525B1 (fr) |
PT (1) | PT1383507E (fr) |
SK (1) | SK287235B6 (fr) |
TW (1) | TWI329512B (fr) |
WO (1) | WO2002085370A1 (fr) |
ZA (1) | ZA200308004B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1603595B1 (fr) * | 2003-02-27 | 2010-11-10 | Eisai R&D Management Co., Ltd. | Composition pharmaceutique pour le traitement de la pharmacodependance |
DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
FR2930891B1 (fr) | 2008-05-06 | 2010-09-24 | Biocodex | Composes anti-amnesiants et compositions pharmaceutiques les comprenant |
EP2586436A1 (fr) * | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Utilisation d'agents anti-connexine pour améliorer l'effet thérapeutique d'un inhibiteur de l'acétylcholinestérase |
WO2016187339A1 (fr) * | 2015-05-18 | 2016-11-24 | Synaptec Development Llc | Clairance de galantamine d'amyloides |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1193061B (de) | 1961-12-20 | 1965-05-20 | Vni Chimiko Pharmazewtitschesk | Verfahren zur Gewinnung von Galanthamin-hydrobromid aus Pflanzen der Familie der Amaryllidaceen |
US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
DE3843239C1 (fr) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5015645A (en) * | 1989-10-19 | 1991-05-14 | Ciba-Geigy Corporation | Tetracyclic pyrrole lactam derivatives |
US5519017A (en) * | 1990-03-29 | 1996-05-21 | Lts Lohmann Therapie-Systeme Gmbh + Co. Kg | Pharmaceutic formulation for the treatment of alcoholism |
DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
DE4301782C1 (de) * | 1993-01-23 | 1994-08-25 | Lohmann Therapie Syst Lts | Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit |
DE19509663A1 (de) | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
WO1998007431A1 (fr) * | 1996-08-22 | 1998-02-26 | New York University | Inhibiteurs de la cholinesterase pour le traitement de la maladie de parkinson |
US5932557A (en) * | 1997-08-12 | 1999-08-03 | Mustafa; S. Jamal | Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments |
EP1231877A4 (fr) * | 1999-11-04 | 2009-03-18 | Xel Herbaceuticals | Administration transdermique d'huperzine |
US20020151591A1 (en) * | 2000-10-17 | 2002-10-17 | Anabella Villalobos | Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders |
-
2001
- 2001-04-24 DE DE10119862A patent/DE10119862A1/de not_active Withdrawn
-
2002
- 2002-04-18 KR KR10-2003-7013971A patent/KR20040005934A/ko active Search and Examination
- 2002-04-18 US US10/475,357 patent/US8207159B2/en not_active Expired - Lifetime
- 2002-04-18 EP EP02764017A patent/EP1383507B1/fr not_active Expired - Lifetime
- 2002-04-18 PL PL366840A patent/PL207525B1/pl not_active IP Right Cessation
- 2002-04-18 CA CA002444818A patent/CA2444818C/fr not_active Expired - Lifetime
- 2002-04-18 ES ES02764017T patent/ES2296990T3/es not_active Expired - Lifetime
- 2002-04-18 AU AU2002308148A patent/AU2002308148B2/en not_active Ceased
- 2002-04-18 MX MXPA03009765A patent/MXPA03009765A/es active IP Right Grant
- 2002-04-18 EA EA200301135A patent/EA200301135A1/ru unknown
- 2002-04-18 BR BR0209126-7A patent/BR0209126A/pt not_active Application Discontinuation
- 2002-04-18 HU HU0401123A patent/HUP0401123A3/hu unknown
- 2002-04-18 PT PT02764017T patent/PT1383507E/pt unknown
- 2002-04-18 IL IL15838202A patent/IL158382A0/xx unknown
- 2002-04-18 SK SK1315-2003A patent/SK287235B6/sk not_active IP Right Cessation
- 2002-04-18 WO PCT/EP2002/004277 patent/WO2002085370A1/fr active IP Right Grant
- 2002-04-18 DE DE50211207T patent/DE50211207D1/de not_active Expired - Lifetime
- 2002-04-18 NZ NZ529004A patent/NZ529004A/en unknown
- 2002-04-18 CN CNB028088905A patent/CN100400043C/zh not_active Expired - Lifetime
- 2002-04-18 DK DK02764017T patent/DK1383507T3/da active
- 2002-04-18 JP JP2002582943A patent/JP2004531533A/ja active Pending
- 2002-04-18 CZ CZ20032789A patent/CZ20032789A3/cs unknown
- 2002-04-18 AT AT02764017T patent/ATE378052T1/de active
- 2002-04-22 TW TW091108204A patent/TWI329512B/zh not_active IP Right Cessation
- 2002-04-24 AR ARP020101482A patent/AR033468A1/es unknown
-
2003
- 2003-10-13 IL IL158382A patent/IL158382A/en active IP Right Grant
- 2003-10-15 ZA ZA200308004A patent/ZA200308004B/en unknown
- 2003-10-23 NO NO20034740A patent/NO20034740L/no not_active Application Discontinuation
-
2004
- 2004-07-02 HK HK04104742A patent/HK1062401A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6377A (is) | Pýrrólidínasetamíð afleiður einar sér eða í samsetningu til meðhöndlunar á truflunum í miðtaugakerfi | |
DK1047428T3 (da) | Anvendelse af morpholinol til behandlingen af seksualforstyrrelser | |
EE200100480A (et) | Ksenoon kasutamiseks närvimürgistuste ravis | |
EE05073B1 (et) | Retigabiin kasutamiseks neuropaatilise valu ravis | |
IS8023A (is) | Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma | |
NO20041588L (no) | Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser | |
NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
NO20031903L (no) | Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser | |
MA29084B1 (fr) | Derives d'indenyle et leur utilisation dans le traitement de troubles neurologiques | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
IS6137A (is) | Meðhöndlun á hugsýkistruflunum | |
NO20030295L (no) | Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser | |
DE60033604D1 (de) | Wärmebehandlung zur Verbesserung der Eigenschaften von Alpha-Beta-Titan-Legierungen | |
EE200200511A (et) | Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks | |
NO20034740L (no) | Anvendelse av galantamin for behandling av patologiske manifestasjoner i sentralnervesystemet grunnet forgiftning med psykotropiskesubstanser | |
NO20024777D0 (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
PT1152756E (pt) | Derivados de anticonvulsivo uteis no tratamento do autismo | |
NO20023803L (no) | Anvendelse av mirtazapin for behandling av sövnforstyrrelser | |
NO20014081D0 (no) | Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier | |
DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
ITRM990707A0 (it) | Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni | |
NO20034741D0 (no) | Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser | |
ID30458A (id) | Osanetan dalam pengobatan gangguan jiwa | |
NO20024331D0 (no) | Behandling av lidelser relatert til det serotonerge system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |